相关实验视频

Updated: Jul 19, 2025

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

伊朗的卵巢癌:国家基础研究

Atieh Akbari¹, Mehdi Azizmohammad Looha¹, Afshin Moradi¹

¹Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Iranian journal of public health

|August 8, 2023

概括

卵巢癌是伊朗第八个最常见的癌症. 与西方国家相比,伊朗妇女的整体生存率更好,五年生存率为55%.

科学领域:

在瘤学瘤学.
流行病学流行病学
公共卫生公共卫生

背景情况:

卵巢癌 (OC) 在全球排名第7位,在伊朗排名第8位.
伊朗妇女的年龄标准化发病率 (ASIR) 为3.9/100,000,之前的研究表明5年生存率约为61%.

研究的目的:

分析伊朗卵巢癌的发病率和存活率.
将伊朗OC统计数据与全球和区域数据进行比较.

主要方法:

利用了伊朗国家癌症登记处2009-2014年间的数据.
采用卡普兰-梅尔生存分析来评估各种人口和病理因素的生存率.
在R和SPSS软件中,使用0.05的P值来确定统计意义.

主要成果:

该研究包括7977个OC病例,总体ASIR为4.10/100,000.
五年和十年的整体生存率分别为55%和45%.
表皮和非特异性OC显示ASIR大于0.5.5.

结论:

与东亚和北美相比,伊朗的卵巢癌发病率较低,生存率更好.
伊朗的OC发病率与总生育率下降和人口老龄化相关,类似于东欧.
较高的生存率可能受到OC晚期患者从病理记录中排除的影响.

关键词:

流行病学流行病学伊朗伊朗伊朗伊朗卵巢癌是发生在卵巢中的癌症.

更多相关视频

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on: September 15, 2023

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...